
Alex T. Devito
Examiner (ID: 13221, Phone: (571)270-7551 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2856, 2855 |
| Total Applications | 868 |
| Issued Applications | 597 |
| Pending Applications | 73 |
| Abandoned Applications | 223 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4559247
[patent_doc_number] => 07838501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-23
[patent_title] => 'Coumermycin/novobiocin-regulated gene expression system'
[patent_app_type] => utility
[patent_app_number] => 10/559411
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7388
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/838/07838501.pdf
[firstpage_image] =>[orig_patent_app_number] => 10559411
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559411 | Coumermycin/novobiocin-regulated gene expression system | Jun 8, 2004 | Issued |
Array
(
[id] => 7275533
[patent_doc_number] => 20040234984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Method'
[patent_app_type] => new
[patent_app_number] => 10/481038
[patent_app_country] => US
[patent_app_date] => 2004-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9157
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20040234984.pdf
[firstpage_image] =>[orig_patent_app_number] => 10481038
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/481038 | Method | Jun 2, 2004 | Abandoned |
Array
(
[id] => 7427688
[patent_doc_number] => 20040209267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Method for identifying interaction between proteins and dna fragments of a genome'
[patent_app_type] => new
[patent_app_number] => 10/480713
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4352
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209267.pdf
[firstpage_image] =>[orig_patent_app_number] => 10480713
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/480713 | Method for identifying interaction between proteins and dna fragments of a genome | May 31, 2004 | Abandoned |
Array
(
[id] => 4879317
[patent_doc_number] => 20080152700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'Methods and compositions for the inhibition of gene expression'
[patent_app_type] => utility
[patent_app_number] => 10/858094
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 74
[patent_no_of_words] => 20978
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20080152700.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858094
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858094 | Methods and compositions for the inhibition of gene expression | May 31, 2004 | Abandoned |
Array
(
[id] => 5649720
[patent_doc_number] => 20060135455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Methods and compositions for the inhibition of gene expression'
[patent_app_type] => utility
[patent_app_number] => 10/858013
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 75
[patent_figures_cnt] => 75
[patent_no_of_words] => 20893
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135455.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858013
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858013 | Methods and compositions for the inhibition of gene expression | May 31, 2004 | Abandoned |
Array
(
[id] => 259715
[patent_doc_number] => 07572437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-11
[patent_title] => 'Long acting human interferon analogs'
[patent_app_type] => utility
[patent_app_number] => 10/851666
[patent_app_country] => US
[patent_app_date] => 2004-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 7
[patent_no_of_words] => 13216
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/572/07572437.pdf
[firstpage_image] =>[orig_patent_app_number] => 10851666
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/851666 | Long acting human interferon analogs | May 23, 2004 | Issued |
| 10/846839 | Novel mutated mammalian cells and animals | May 13, 2004 | Abandoned |
Array
(
[id] => 7122344
[patent_doc_number] => 20050014173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Parkinson\'s disease markers'
[patent_app_type] => utility
[patent_app_number] => 10/839688
[patent_app_country] => US
[patent_app_date] => 2004-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17055
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014173.pdf
[firstpage_image] =>[orig_patent_app_number] => 10839688
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/839688 | Parkinson's disease markers | May 4, 2004 | Abandoned |
Array
(
[id] => 7326884
[patent_doc_number] => 20040253231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Novel card proteins involved in cell death regulation'
[patent_app_type] => new
[patent_app_number] => 10/828920
[patent_app_country] => US
[patent_app_date] => 2004-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 23372
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20040253231.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828920
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828920 | Novel card proteins involved in cell death regulation | Apr 19, 2004 | Abandoned |
Array
(
[id] => 4996413
[patent_doc_number] => 20070011758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Mouse with deficiency of glutamate transporter glast function'
[patent_app_type] => utility
[patent_app_number] => 10/553051
[patent_app_country] => US
[patent_app_date] => 2004-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9586
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0011/20070011758.pdf
[firstpage_image] =>[orig_patent_app_number] => 10553051
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/553051 | Mouse with deficiency of glutamate transporter GLAST function | Apr 12, 2004 | Issued |
Array
(
[id] => 7441146
[patent_doc_number] => 20040185497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Method and kit for the screening, the detection and/or the quantification of transcriptional factors'
[patent_app_type] => new
[patent_app_number] => 10/821568
[patent_app_country] => US
[patent_app_date] => 2004-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8681
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20040185497.pdf
[firstpage_image] =>[orig_patent_app_number] => 10821568
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/821568 | Method and kit for the screening, the detection and/or the quantification of transcriptional factors | Apr 7, 2004 | Abandoned |
Array
(
[id] => 5677865
[patent_doc_number] => 20060183221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Method for neural differentiation of embryonic stem cells using protease passaging techniques'
[patent_app_type] => utility
[patent_app_number] => 10/551603
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 30656
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183221.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551603
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551603 | Method for neural differentiation of embryonic stem cells using protease passaging techniques | Mar 30, 2004 | Abandoned |
Array
(
[id] => 7249533
[patent_doc_number] => 20040258683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Methods of treating and monitoring systemic lupus erythematosus in individuals'
[patent_app_type] => new
[patent_app_number] => 10/814555
[patent_app_country] => US
[patent_app_date] => 2004-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 26291
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20040258683.pdf
[firstpage_image] =>[orig_patent_app_number] => 10814555
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/814555 | Methods of treating and monitoring systemic lupus erythematosus in individuals | Mar 29, 2004 | Abandoned |
Array
(
[id] => 7263409
[patent_doc_number] => 20040241698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Method for producing a normalized gene library from nucleic acid extracts of soil samples and the use thereof'
[patent_app_type] => new
[patent_app_number] => 10/490304
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8353
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241698.pdf
[firstpage_image] =>[orig_patent_app_number] => 10490304
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/490304 | Method for producing a normalized gene library from nucleic acid extracts of soil samples and the use thereof | Mar 18, 2004 | Abandoned |
Array
(
[id] => 5184700
[patent_doc_number] => 20070056054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Model for muscular dystrophy and cardiomyopathy'
[patent_app_type] => utility
[patent_app_number] => 10/549507
[patent_app_country] => US
[patent_app_date] => 2004-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6966
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20070056054.pdf
[firstpage_image] =>[orig_patent_app_number] => 10549507
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/549507 | Model for muscular dystrophy and cardiomyopathy | Mar 17, 2004 | Abandoned |
Array
(
[id] => 7301020
[patent_doc_number] => 20040216174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Screening assays for targets and drugs useful in treatment and prevention of lipid metabolism disorders'
[patent_app_type] => new
[patent_app_number] => 10/800333
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 54734
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20040216174.pdf
[firstpage_image] =>[orig_patent_app_number] => 10800333
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/800333 | Screening assays for targets and drugs useful in treatment and prevention of lipid metabolism disorders | Mar 11, 2004 | Abandoned |
Array
(
[id] => 4572979
[patent_doc_number] => 07824907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-02
[patent_title] => 'Expression vectors comprising the mCMV IE2 promoter'
[patent_app_type] => utility
[patent_app_number] => 10/548364
[patent_app_country] => US
[patent_app_date] => 2004-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 22
[patent_no_of_words] => 11248
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/824/07824907.pdf
[firstpage_image] =>[orig_patent_app_number] => 10548364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/548364 | Expression vectors comprising the mCMV IE2 promoter | Mar 9, 2004 | Issued |
Array
(
[id] => 7462124
[patent_doc_number] => 20040166097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Isolated stromal cells and methods of using the same'
[patent_app_type] => new
[patent_app_number] => 10/787506
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16103
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20040166097.pdf
[firstpage_image] =>[orig_patent_app_number] => 10787506
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/787506 | Isolated stromal cells and methods of using the same | Feb 25, 2004 | Abandoned |
Array
(
[id] => 7136032
[patent_doc_number] => 20050181035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Systemic immune activation method using non CpG nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 10/780294
[patent_app_country] => US
[patent_app_date] => 2004-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 29430
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181035.pdf
[firstpage_image] =>[orig_patent_app_number] => 10780294
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/780294 | Systemic immune activation method using non CpG nucleic acids | Feb 16, 2004 | Abandoned |
Array
(
[id] => 7107896
[patent_doc_number] => 20050108782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Transgenic RS1-/- animal and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/771151
[patent_app_country] => US
[patent_app_date] => 2004-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13526
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20050108782.pdf
[firstpage_image] =>[orig_patent_app_number] => 10771151
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/771151 | Transgenic RS1-/- animal and uses thereof | Feb 3, 2004 | Abandoned |